awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43067104-4914FD7A-A744-435D-94ED-E3BC0E1B0C4D
Q43067104-4914FD7A-A744-435D-94ED-E3BC0E1B0C4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43067104-4914FD7A-A744-435D-94ED-E3BC0E1B0C4D
Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211.
P2860
Q43067104-4914FD7A-A744-435D-94ED-E3BC0E1B0C4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43067104-4914FD7A-A744-435D-94ED-E3BC0E1B0C4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb2b1be455a332238a3ea608813b0fc2fc98d194
P2860
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.